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Abstract 
Alginate microspheres are considered a promising material as a drug carrier in bone repair due to 
excellent biocompatibility, but their main disadvantage is low drug entrapment efficiency and 
non-controllable release.  The aim of this study was to investigate the effect of incorporating 
mesoporous bioglass (MBG), non-mesoporous bioglass (BG) or hydroxyapatite (HAp) into alginate 
microspheres on their drug-loading and release properties.  X-ray diffraction (XRD), transmission 
electron microscopy (TEM), scanning electron microscopy (SEM), Fourier transform infrared 
spectroscopy (FTIR), and atomic emission spectroscopy (AES) were used to analyse the 
composition, structure and dissolution of bioactive inorganic materials and their microspheres.  
Dexamethasone (DEX)-loading and release ability of four microspheres were tested in phosphate 
buffered saline with varying pHs.  Results showed that the drug-loading capacity was enhanced 
with the incorporation of bioactive inorganic materials into alginate microspheres.  The 
MBG/Alginate microspheres had the highest drug loading ability.  DEX release from alginate 
microspheres correlated to the dissolution of MBG, BG and HAp in PBS, and that the pH was an 
efficient factor in controlling the DEX release; a high pH resulted in greater DEX release, whereas a 
low pH delayed DEX release.  In addition, MBG/alginate, BG/alginate and HAp/alginate 
microspheres had varying apatite-formation and dissolution abilities, which indicate that the 
composites would behave differently with respect to bioactivity.  The study suggests that 
microspheres made of a composite of bioactive inorganic materials and alginate have a bioactivity 
and degradation profile which greatly improves their drug delivery capacity, thus enhancing their 
potential applications as bioactive filler materials for bone tissue regeneration. 
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INTRODUCTION 
The use of bioactive microspheres as protein/drug carriers and bone filling materials has received 
much attention in recent years.1-4  Compared to traditional macroporous block scaffolds, the main 
advantage of microspheres is that they not only possess better drug-delivering properties, but also 
the ability to fill bone defects of irregular and complex shapes and sizes.  However, for 
microspheres to become a bone fide application in bone-tissue regeneration there are three major 
issues that needs to be resolved: (i) controllability of drug-release; (ii) bioactivity; and (iii) 
degradability.  At present, the key obstacles concerning the clinical use of both polymer5,6 and 
ceramic3,7,8 microspheres in bone-tissue regeneration, is the sub-optimal combination of these three 
properties.  
Calcium alginate is considered one of promising material as a delivery matrix, because gel beads 
forms readily in aqueous solutions at room temperature, without the need for organic solvents.2,9  
An added attraction is that alginate gels dissolve under physiological conditions, and they have been 
demonstrated to be biocompatible.10,11  For these reasons, alginate has been proposed as a potential 
bone regeneration material, when prepared as a composite with hydroxyapatite (or -tricalcium 
phosphate), which greatly improves its biomechanical and bioactive properties.12-14  However, it 
falls well short as a drug carrier, owing to the fact that calcium alginate microspheres have low drug 
entrapment efficiency and non-controllable release kinetics.15  Mesoporous bioactive glass is a 
novel class of bioglass with a highly ordered mesopore channel structure and pore sizes ranging 
from 2-50 nm.16  A prominent feature of MBG is its greater surface area and pore volume, greatly 
enhanced drug-delivery kinetics,17 and superior bioactivity compared to non-mesoporous bioglass 
(BG).16  In a previously published study we have shown that MBG dissolves at a faster rate than 
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BG.18  HAp is a well known inorganic bioactive material and its rate of dissolution is slower still 
than that of bioactive glass.  In this study we therefore set out to test whether an alginate 
composite with MBG, BG, or HAp, would result in materials with an improved bioactivity and 
controllable drug-release profile.  We hypothesized that this might be the case, by virtue of their 
different rates of dissolution, and also given that alginate is a pH sensitive gel and that its rate of 
dissolution can be adjusted by pH.9,19,20  The principal aim of this study was therefore to 
incorporate MBG, BG or HAp into alginate microspheres in order to control their drug-loading and 
release properties. 
 
MATERIALS AND METHODS 
Synthesis and characterization of MBG, BG and HAp powders 
Mesoporous Bioglass (MBG) powders (molar ratio: Si/Ca/P = 80/15/5) were synthesized 
according to our previous publication.18,21  In a typical synthesis, 4.0 g of P123 (EO20-PO70-EO20, 
Mw=5800, Sigma), 6.7 g of tetraethyl orthosilicate (TEOS), 1.4 g of Ca(NO3)2·4H2O, 0.73 g of 
triethyl phosphate (TEP, 99.8%, Sigma) and 1.0 g of 0.5M HCl were dissolved in 60 g of ethanol 
(Si/Ca/P = 80:15:5, molar ratio) and stirred at room temperature (RT) for 1 day. The resulting 
solution was introduced into a petri dish for an evaporation-induced self-assembly process, and then 
the dry gel was calcined at 700 ºC for 5 hr to obtain MBG powders. Non-mesoporous bioglass (BG) 
powders were synthesized without the addition of P123 under the same conditions and used as a 
control. The synthesized MBG and BG powders were ground and sieved to 230 meshes, and the 
inner microstructure of the powders was inspected by TEM.  
The hydroxyapatite (HAp) powders were synthesized by a chemical precipitation method.  
Briefly, 0.1M Ca(NO3)2 water solution (100ml) was dropped into 0.06M (NH4)2HPO4 solution 
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(100ml) under stirring for 12 hr and maintained a pH above 10.  The resulting powders were 
filtered and washed three times in water and once in ethanol, then dried at 60 ºC for 24 hr and 
calcined at 800 ºC for 2 hr.  The HAp powders were analyzed by TEM and XRD and surface area 
analyzed by Brunauer-Emmett-Teller (BET) method. 
Preparation and characterization of DEX-loaded Alginate, MBG/Alginate, BG/Alginate and 
HAp/Alginate microspheres 
Dexamethasone (DEX) (Sigma-Aldrich, Australia) was used for the drug loading and release 
kinetics studies, at a final concentration of 0.1mg/ml in water (S/L).  3.125g of MBG, BG or HAp 
powders were added to 40ml DEX solution and stirred for 4 hr.  Alginate powder (viscosity 
20-40Cp, Sigma), was dissolved in water at a 3% (w/v) concentration, and the alginate solution was 
then added to all of MBG, BG and HAp slurries, stirred for 1 hr and ultra-sonicating 5 min to form 
homogenous mixtures.  The mass ratio of inorganic powders/alginate is 1.67. The mixtures were 
extruded drop-wise with a 0.65mm diameter needle into a 0.1 M CaCl2 crosslinking solution to 
form spherical particles.  The microspheres were hardened by 30 min immersion in the 
crosslinking solution, then filtered and dried at 50ºC overnight to obtain DEX-loaded composite 
microspheres.  The CaCl2 solution from the filtering step was collected for later assaying of the 
residual DEX content.  Pure alginate microspheres were prepared without adding any inorganic 
bioactive powders using the same procedure as above.  The surface morphology and 
microstructure of the dried microspheres was analyzed by SEM and their components analyzed by 
FTIR. 
In vitro acellular tests in SBF of four types of microspheres 
A short term in vitro bioactivity study was carried out using acellular simulated body fluids (SBF).22  
SBF has similar ion concentrations to human blood plasma.  Briefly, reagent-grade CaCl2, 
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K2HPO4·3H2O, NaCl, KCl, MgCl2·6H2O, NaHCO3, and Na2SO4 were dissolved in distilled water 
and pH adjusted to 7.4 with HCl and Tris.  The four different microspheres species were immersed 
in SBF, and kept under static conditions at 37 ºC for 5 days, after which they were dried at 60ºC for 
1 day and analyzed by SEM and energy dispersive spectrometer (EDS), to determine their 
apatite-formation abilities. 
The effect of bioactive microspheres on the proliferation of bone marrow stromal cells 
(BMSCs) 
    Isolation and culture of BMSCs was conducted following previously published protocols.23 
BMSCs (1x105/well) were seeded on 96-well template and allowed to adhere to the template for 3 
hr. Then, microspheres were added to the template.  The cells were incubated for 3 and 7 days, at 
which point the medium was replaced with 20 μL of CellTiter 96 Aqueous One Solution Reagent 
(Promega, Genesearch, QLD, Australia) in 100 μL PBS.  After 4 hr in culture, the cell viability was 
determined by measuring the absorbance at 490 nm on a 96 well plate-reader. 
The loading efficiency of DEX in four microspheres 
To evaluate the DEX-loading efficiencies of the four microsphere species, the CaCl2 solution 
was collected after the microspheres had been filtered, to test the residual DEX contents (RDEX) by 
UV/VIS.  The loading efficiency (LE%) of DEX was calculated using the following equation: 
LE% = ((ODEX – RDEX)/ODEX)* 100%, where ODEX was the original DEX contents in the solution 
prior to preparing the microspheres. 
DEX release from the microspheres in PBS with different pH value 
To evaluate what effects the different bioactive inorganic materials and pH environment had on 
DEX release, the DEX-loaded microspheres (0.6g for alginate composite microspheres, 0.225g for 
pure alginate microspheres) were placed in 5ml phosphate buffered saline (PBS) (pH = 4.3, 7.4 and 
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8.6) at 37 ºC for 1, 3, 6 hr, and 1, 3, 7, 11 and 18 days.  The PBS pH was adjusted with HCl and 
Tris.  At each time point, the entire 5ml PBS solution was taken off and replaced with 5ml of fresh 
PBS.  The amount of DEX released in the PBS was then assayed by UV/VIS at the wavelength of 
241nm.  Three samples from each microsphere species were taken for mean and standard 
deviation calculation. 
Ions release and morphology change of microspheres in PBS with different pH value 
To evaluate what effect pH had on the ions-release ability (dissolution) of microspheres in PBS, 
the accumulative ions release for Ca, Si and P ions in PBS at days 1, 3 and 7 were tested by 
inductively coupled plasma atomic emission spectroscopy (ICP-AES).  The morphology change of 
the different microspheres, after 18 days in PBS, was analyzed by SEM. 
Statistical analysis 
The data was expressed as means ± standard deviation (SD) for all experiments and were analyzed 
using one-way ANOVA with a post hoc test, where p-value < 0.05 was considered statistically 
significant. 
 
RESULTS 
Characterization of MBG, BG and HAp powders 
The inner structure and particle morphology of the synthesized bioactive inorganic powders 
were analysed by TEM, and is shown in Figure 1.  The MBG powders had a highly ordered 
one-dimensional channel structure with a pore size of approximately 5nm (Fig. 1a).  In contrast, 
the BG powders had a disorganized structure, lacking any discernible channels (Fig. 1b).  The 
HAp particles, which had a size of approximately 200 nm, were composed of crystalline structures 
with a size ranging over several tens of nanometers (Fig. 1c). 
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The phase composition of the obtained HAp powders is shown in Figure 2.  As expected, only the 
characteristic peaks of HAp (Standard cards No: JCPD 24-0033) were seen in the XRD pattern, 
proof that the obtained powders were indeed pure HAp.  
The surface area of the MBG powder was estimated to be 400m2/g, which was significantly greater 
than that of the HAp powder at 68 m2/g, and BG powder at 57 m2/g.  
Morphology, surface microstructure and components of the four microsphere species 
The morphology and surface microstructure of the microspheres is shown in Figure 3.  The 
pure alginate microspheres had a smooth surface and slightly oblong shape, and a size of 
approximately 600 µm (Fig. 3a and b).  The MBG/Alginate, BG/Alginate and HAp/Alginate 
composite microspheres all had a more uniformly round shape compared to the pure alginate 
microspheres (Fig. 3c, d, e, f, g and h), the size of all three composites being approximately 800µm.  
The surfaces of the MBG/Alginate and BG/Alginate microspheres were coarser than the surface of 
the pure alginate and HAp/Alginate microspheres (Fig. 3c, d, e, f, g and h).  
FTIR spectra for the four species revealed the presence of silicon oxide (SiO) in the MBG/Alginate 
and BG/Alginate composites, and a prominent peak of phosphorous oxide (PO) in the 
HAp/Alginate composite.  Evidence of carbon oxides (CO) and carboxylate (COO-) from the 
alginate is seen in all four spectra (Fig. 4).  
Apatite-formation capacity of the four microsphere species in SBF 
SEM morphology and EDS analysis of the microsphere species after 5 day incubation in SBF is 
shown in Figure 5.  MBG/Alginate microspheres induced apatite particle deposition on their 
surface (Fig. 5c) and high magnification SEM revealed that apatite particles had formed a porous 
layer (Fig. 5d).  EDS analysis showed that the ratio of Ca/P of this formed apatite was about 1.57. 
There was no obvious apatite particles formation on the other three microspheres (Fig. 5a, b, e, f, g 
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and h).  The surface of the pure alginate microspheres was smooth and there was no evidence of 
Ca and P from the EDS analysis (Fig. 5a and b).  The BG/Alginate microspheres, similarly, did not 
induce any apatite deposition and only Si was detected by EDS (Fig. 5e and f).  After 5 days in 
SBF the surface of the HAp/Alginate microspheres appeared to be smoother than prior to soaking. 
The Ca/P ratio of the SBF exposed HAp particles was 1.67, which is the same stoichiometry as the 
HAp materials. 
The effect of bioactive microspheres on the proliferation of bone marrow stromal cells 
(BMSCs) 
The effect of four microspheres on BMSC proliferation was shown in Figure 6. After incorporation 
of bioactive MBG, BG and HAp into alginate, the proliferation of BMSC has been significantly 
enhanced. 
DEX-loading efficiency and release of the four microsphere species  
Pure alginate microspheres had the lowest DEX-loading efficiency of the four microsphere 
species with an estimated 39% efficiency (Table 1).  Incorporating MBG, BG, or HAp into the 
microspheres improved their loading efficiencies.  MBG/Alginate microspheres showed highest 
loading efficiency compared to those of HAp/Alginate and BG/Alginate microspheres (Table 1). 
The results of the effect of different pH values on the release of DEX from the four materials are 
shown in Figure 7.  The incorporation of MBG and BG into alginate microspheres significantly 
enhanced DEX release rate across the range of pH environments, and after 18 days of soaking in 
PBS the MBG/Alginate showed the greatest rate of release of the four microsphere species.  
Interestingly, with the HAp/Alginate microspheres the DEX release increased between pH 4.3 and 
7.4, but then showed a decrease at pH 8.6 (Fig. 7c). 
The effect of the pH value of PBS on DEX release from the different microspheres is shown in 
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Figure 8.  With both the MBG/Alginate and BG/Alginate microspheres, DEX release increased 
with an increase of the pH value in PBS (Fig. 8b and c).  There was no obvious effect on DEX 
release from pure alginate and HAp/Alginate microspheres when pH was between 4.3 and 7.4, 
however, at pH 8.6, DEX release was significantly enhanced (Fig. 8a and d). 
Ions release and morphology changes of the microspheres in PBS with different pH value 
The release of Si ions into PBS was greater in MBG/Alginate than in BG/Alginate microspheres 
and was unaffected by the pH value (Fig. 9a).  MBG/Alginate microspheres also released more Ca 
ions than BG/Alginate microspheres (Fig. 9b).  There was an obvious effect of pH on P ions 
release from HAp/Alginate microspheres (Fig. 9c); at a pH between 7.4 and 4.3 there was a slow 
increase in P ions release commensurate with soaking time, however, P ions release decreased 
dramatically at pH 8.6 (Fig. 9c).  
The surface morphology of the four microsphere species, after 18 days incubation in PBS with 
different pH values, is shown in Figure 10.  At low pH (4.3) the morphology and microstructure of 
all four microsphere species remained unchanged (Fig. 10a, c, e and f).  At high pH (8.6) there was 
a clearly discernible change of microstructure of the microspheres.  The shape of the pure alginate 
microspheres became irregular and there were large pores up to 300µm across on the surface these 
spheres (Fig. 10b).  The MBG, BG and HAp composite microspheres retained their round shape 
(Fig. 10d, f and h).  When incubated in high pH PBS, the surfaces of the composite microspheres 
became coarser than those incubated in low pH PBS.  There was also evidence of some 
micro-particle deposition on the surface of the microspheres incubated in high pH PBS (Fig. 10d, f 
and h). 
DISCUSSION 
In this study we have demonstrated that the incorporation of bioactive inorganic materials with 
 11
alginate into microspheres enhances their drug-loading ability and release kinetics.  The composite 
microspheres were developed by incorporating MBG, BG or HAp into alginate and controlling the 
pH environment.  These composite microspheres combined better bioactivity, degradability and 
controllable drug delivery properties, which enhanced their potential for bone tissue regeneration 
applications.  
The major disadvantage of calcium alginate microspheres is large gel porosity which causes 
leakage of drugs, low drug entrapment efficiency, and non-controllable protein release.15  In an 
effort to solve these problems, three different inorganic bioactive materials (MBG, BG and HAp) 
were successfully incorporated into alginate microspheres.  The incorporation of these materials 
enhanced the drug-entrapment efficiency of alginate, and this was demonstrated by the increased 
DEX-loading ability of the composite microspheres.  The composites had increased surface areas 
compared to the pure alginate microspheres.  MBG/Alginate microspheres possess the highest 
loading ability. The greater loading efficiencies may therefore be the result of the larger surface 
areas containing more hydroxyl groups.  A study by Xia and colleagues have shown that the drug 
molecules interact with the surface by hydrogen bonds.17  
The incorporation of bioactive inorganic materials into alginate not only enhances drug-loading 
ability, but can also improve the drug release kinetics from microspheres.  DEX release rates 
increased in alginate microspheres containing HAp, BG and MBG, in that order.  It is known that 
the dissolution of materials is one of the most important factors that influence drug release.24-26  Of 
the three materials MBG, BG and HAp, it was found that MBG had a more rapid ion release than 
both BG and HAp, which indicated that MBG had highest dissolution in PBS.  It is therefore 
reasonable to speculate that different rates of dissolution of MBG, BG and HAp may be the main 
contributing factor influencing DEX release in the composite microspheres.  
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The pH is another important environment parameter in a drug-delivery system, given that the pH 
changes occurs locally or at pathological sites within the body, such as in the stomach, the intestines, 
endosomes, lysosomes, blood vessels, the female reproductive tract, and different tumorous 
extracellular sites.27,28  A pH-sensitive drug-delivery system has therefore attracted considerable 
interest.  In this study we found that the pH value of PBS was a crucial factor with which to 
control the DEX release from the four species of microspheres.  Generally, the higher the pH value 
(alkaline environment) the greater the amount of DEX release, whereas a lower pH value (acidic 
environment) suppressed the release of DEX.  Previous studies have shown that the dissolution of 
alginate is influenced by the surrounding pH and that a low pH decreases the dissolution of alginate 
due to the suppressing effect on the dissociation of carboxyl groups in alginate molecules.19,20  Our 
results from SEM analysis of the microspheres after soaking in PBS (Fig. 10) clearly indicated that 
a higher PBS pH induced greater erosion and deformation of the alginate microspheres than did a 
lower pH value.  The pH may therefore predominantly influence the dissolution of microspheres 
and further control DEX release.  Figure 11 illustrates this hypothesis as to how the pH may 
influence the DEX release in the microspheres.  
Interestingly, when the PBS pH was between 4.3 and 7.4, the HAp/Alginate microspheres 
showed an increased DEX release rate, whereas DEX release decreased at pH 8.6 (Fig. 7c).  In 
addition, P ion release into the PBS also decreased at pH 8.6, suggesting that HAp/Alginate 
microspheres may absorb P ions from the PBS and form apatite particles on the surface of 
microspheres.  Previous studies have shown that apatite does inhibit drug release due to its 
nanostructure.18,29  It is therefore possible that at pH 8.6, some apatite particles may have been 
deposited on the surface of the HAp/Alginate microspheres, and this might have led to the decrease 
of DEX release compared to pure alginate microspheres. Although MBG and BG contained alginate 
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microspheres have higher apatite-formation ability than HAp/Alginate, however, MBG/alginate and 
BG/Alginate microspheres have quicker dissolution than HAp/Alignate, which results in higher 
DEX release from MBG/alginate and BG/Alginate microspheres than that from HAp/Alignate and 
pure alginater microspheres. The local pH condition encountered in bone varies. Previous studies 
have shown that the local pH around the ruffled border of osteoclasts is about 4.0 during bone 
remodelling,30,31 and the homeostatic body fluid is about pH 7.4.  Further study showed that the 
local environment in the initial fracture hematoma is acidic, which later becomes neutral as the 
healing progresses and ultimately, alkaline which helps to support differentiation-related events in 
the healing process.32  Therefore, our study was carried out in PBS buffer with varying pH 
condition to simulate the local pH environment in bone. Our study has shown that the drug release 
from bioactive MBG, BG or HAp/alginate microspheres is pH sensitive. These bioactive 
microspheres may be used for drug carrier to control drug delivery in varying pH condition 
encountered by bone. 
A further disadvantage with using pure alginate for microspheres is the material’s failure to retain 
its original shape.13  It has been shown that after desiccation, the shape of the pure alginate 
microspheres could not be maintained due to their low intrinsic strength.  However, after 
incorporating MBG, BG or HAp into the alginate, the native round shape of the microspheres was 
retained, indicating that the inorganic materials had a reinforcing effect on the microspheres.  
There is an unmet demand for bioactive materials, with a range of degradation rates and 
bioactivities, for applications in bone repair and bone tissue engineering.33,34  This is why 
microspheres made from bioactive inorganic materials and alginate composites, such as those 
described in this study, would be a useful contribution from the point of view of clinical 
applications.  Our previous studies have shown that MBG has a better bioactivity profile than BG, 
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due to the former’s special nano-channel structure.21  In this study, our results show that 
MBG/Alginate has better in vitro apatite-formation abilities than the three other types of 
microspheres tested.  These results further suggest that MBG containing microspheres may have a 
greater in vivo potential for bone-formation than the other three microspheres species.  In addition 
to this, our results showed that ion release from the MBG containing microspheres was greater than 
BG and HAp microspheres, which strongly suggest that MBG/Alginate composites may have a 
more rapid rate of in vivo degradation than do BG and HAp microsphere.  In addition, the 
incorporation of bioactive inorganic materials into alginate significantly enhanced BMSCs 
proliferation. The potential reason may be relative to the stimulatory effect of the released bioactive 
ions from composites microspheres. Therefore, considering their obvious difference in the 
drug-delivery properties, bioactivity and degradation of four kinds of alginate microspheres, they 
may have potential to be used for different clinical applications as bone filling materials.  Further 
in vivo experiments will be needed to confirm whether this is indeed the case. 
 
CONCLUSIONS 
Bioactive inorganic materials/Alginate composite microspheres were successfully prepared using 
the method of alginate crosslinking to CaCl2 solution by incorporating MBG, BG or HAp into 
alginate.  The incorporation of bioactive inorganic materials into alginate microspheres showed 
enhanced drug-loading efficiency.  The drug release from alginate microspheres could be 
controlled by altering the three inorganic materials.  In addition to this, the pH was shown to be 
another efficient tool to control the protein release from the composite microspheres.  Therefore, 
the drug-delivery ability of bioactive inorganic materials/Alginate composite microspheres has been 
controlled by varying three bioactive inorganic materials and pH environment. MBG/Alginate, 
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BG/Alginate and HAp/Alginate microspheres possess different bioactivity and degradation ability, 
indicating their potential application as bioactive filler materials for bone tissue regeneration. 
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Figure captions 
Figure 1. TEM microstructure of MBG (a), BG (b) and HAp (c) powders. 
Figure 2. XRD analysis of HAp powders synthesized by chemical precipitation. 
Figure 3. SEM morphology of different microspheres. Alginate (a) and (b); MBG/Alginate (c) and 
(d); BG/Alginate (e) and (f); HAp/Alginate (g) and (h).  (b), (d), (f) and (h) are higher 
magnification SEM. 
Figure 4. FTIR spectra of Alginate, MBG/Alginate, BG/Alginate and HAp/Alginate microspheres. 
Figure 5. SEM morphology and EDS analysis of different microspheres in SBF for 5 days. Alginate 
(a) and (b); MBG/Alginate (c) and (d); BG/Alginate (e) and (f); HAp/Alginate (g) and (h). (b), (d), 
(f) and (h) are higher magnification SEM. The ratio of Ca/P of the formed apatite on MBG/Alginate 
microspheres is 1.57 (d). The ratio of Ca/P for the HAp/Alginate is 1.67 (h). There is no obvious 
apatite formation on pure Alginate, BG/Alginate and HAp/Alginate microspheres after soaking in 
SBF for 5 day. 
Figure 6. The effect of microspheres on BMSCs proliferation. 
Figure 7. The effect of different materials on DEX release in PBS with different pH values (a) 4.3, 
(b) 7.4 and (c) 8.6. 
Figure 8. The effect of pH value of PBS on DEX release for different microspheres (a) Alginate, (b) 
MBG/Alginate, (c) BG/Alginate and (d) HAp/Alginate. 
Figure 9. The accumulative release of Ca, Si and P ions from different microspheres after DEX 
release in PBS. 
Figure 10. SEM morphology of different microspheres after DEX release in PBS for 18 days. 
Alginate (a) and (b); MBG/Alginate (c) and (d); BG/Alginate (e) and (f); HAp/Alginate (g) and (h).  
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(a), (c), (e) and (g) in PBS with the pH value 4.3. (b), (d), (f) and (h) in PBS with the pH value 8.6. 
Figure 11.The schematic illustration of pH-controlled DEX release from composite microspheres. 
 
